The number of deaths caused by heart disease has decreased in the United States from ***** per 100,000 population in 1990 to ***** deaths per 100,000 population in 2019. Nevertheless, heart disease is still the leading cause of death in the country, followed closely by cancer, which has a mortality rate of ***** per 100,000 people. Heart disease in the U.S.Diseases of the heart and blood vessels are often associated with atherosclerosis, which occurs when plaque builds up along arterial walls. This can limit the flow of blood and can lead to blood clots, a common cause of stroke or heart attacks. Other types of heart disease include arrhythmia (abnormal heart rhythms) and heart valve problems. Many of these diseases can be treated with medication, although many complications will still remain. One of the leading cholesterol lowering drugs in the United States, Crestor, generated around **** billion U.S. dollars of revenue in 2024. Risk Factors for heart disease There are many risk factors associated with the development of heart disease, including family history, ethnicity, and age. However, there are other factors that can be modified through lifestyle changes such as physical inactivity, smoking, and unhealthy diets. Obesity has also been commonly associated with risk factors like hypertension and diabetes type II. In the United States, some ** percent of white adults are currently obese.

In 2022, South Korea had the lowest rate of death from ischemic heart disease among OECD countries, with around ** deaths per 100,000 inhabitants. In comparison, there were around *** deaths due to ischemic heart disease per 100,000 population in Lithuania. Cardiovascular disease worldwide Fatty deposits accumulating in the inner wall of the coronary artery that restrict blood flow to the heart cause ischemic heart disease (IHD) and can also precipitate heart attacks and strokes. Cardiovascular risk factors such as smoking, heavy alcohol use, and an unhealthy diet are more prevalent in Eastern European countries, contributing to a much higher burden of cardiovascular diseases and deaths. Prevention and intervention Invasive interventions for heart disease can include surgical procedures such as heart bypass surgery- where blood is diverted around clogged parts of major arteries. Other medical interventions include the use of prescribed or over-the-counter drugs, such as prescription nitrates or beta blockers, or OTC medications like aspirin. Lifestyle factors to lower blood pressure and cholesterol levels can help decrease the risk of heart attacks and other cardiovascular diseases, including maintaining a healthy diet, regular physical activity, and smoking and alcohol cessation.

2019–2020. The National Health Interview Survey (NHIS) has monitored the health of the nation since 1957. NHIS data on a broad range of health topics are collected through personal household interviews. Indicators for this dataset has been computed by personnel in CDC's Division for Heart Disease and Stroke Prevention (DHDSP). This was one of the datasets provided by the National Cardiovascular Disease Surveillance System and presented on DHDSP’s Data, Trends, and Maps online tool. This tool was retired in April of 2024 and this dataset will not be updated. Contact dhdsprequests@cdc.gov if you need assistance with data previously included in this dataset. The data are organized by location (region) and indicator, and they include CVDs (e.g., heart failure) and risk factors (e.g., hypertension). The data can be plotted as trends and stratified by age group, sex, and race/ethnicity.

Splitgraph serves as an HTTP API that lets you run SQL queries directly on this data to power Web applications. For example:

See the Splitgraph documentation for more information.

This statistic displays the number of inpatients diagnosed with diseases of the circulatory system in the United Kingdom from 2012/13 to 2023/24, by disease. In 2023/24, approximately *** thousand people in the United Kingdom were diagnosed with coronary heart disease, while ***** thousand were diagnosed with a stroke.

This dataset, compiled by the Center for Medicare & Medicaid Services (CMS), includes Medicare and Medicaid claims data from 2016 to 2021. It covers a variety of categories such as Inpatient and Outpatient claims and Master Beneficiary Summary Files. Indicators were computed by the CDC's Division for Heart Disease and Stroke Prevention (DHDSP) and were previously available on the National Cardiovascular Disease Surveillance System and DHDSP’s Data, Trends, and Maps online tool, which was retired in April 2024.

Key features of the dataset:

Organized by location (national and state levels) and indicator.
Trends can be plotted and stratified by sex and race/ethnicity.
Useful for analyzing cardiovascular disease trends and related health disparities.

For assistance with data previously included in this dataset, contact dhdsprequests@cdc.gov. Note that this dataset will no longer be updated.

1999–2000 to 2017–2018. The National Health and Nutrition Examination Survey (NHANES) is a program of studies designed to assess the health and nutritional status of adults and children in the United States. The survey is unique in that it combines interviews and physical examinations. Indicators from this data source have been computed by personnel in CDC's Division for Heart Disease and Stroke Prevention (DHDSP). This was one of the datasets provided by the National Cardiovascular Disease Surveillance System and presented on DHDSP’s Data, Trends, and Maps online tool. This tool was retired in April of 2024 and this dataset will not be updated. Contact dhdsprequests@cdc.gov if you need assistance with data previously included in this dataset. The data can be plotted as trends and stratified by age group, sex, and race/ethnicity.

Snapshot img

Cardiovascular Medical Devices Market Size 2025-2029

The cardiovascular medical devices market size is forecast to increase by USD 21.71 billion at a CAGR of 7.6% between 2024 and 2029.

The market is driven by the escalating incidence of cardiovascular diseases and the expansion of insurance providers' coverage for related treatments. Market players are responding with innovative business strategies, including product development and strategic collaborations, to capitalize on these opportunities. However, the high cost of cardiovascular procedures poses a significant challenge for both patients and providers, potentially limiting market growth. Artificial intelligence and wireless technologies, such as Al-based electrocardiograms, implantable loop recorders, and event monitors, are also gaining popularity for their ability to improve diagnostic accuracy and patient care.
Effective cost management and continuous innovation will be essential for market success. As the population ages and cardiovascular diseases become increasingly prevalent, companies must navigate this financial obstacle while maintaining quality and affordability to meet patient needs and remain competitive. Companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis.

What will be the Size of the Cardiovascular Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The Cardiovascular Devices Market encompasses diagnostic monitoring devices, surgical devices, and cardiology devices used to prevent and manage heart disorders, including cardiomyopathy, heart failure, stroke, and heart-related mortality. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, making this market crucial for addressing healthcare resources and improving patient outcomes. Emerging nations are increasingly investing in advanced cardiovascular devices, such as AI-based ECG technology and minimally invasive procedures, to reduce fatal conditions like heart failure and stroke. The market is witnessing significant trends, including the integration of artificial intelligence in diagnostics and the development of more sophisticated surgical devices, such as coronary artery stents.

Cardiovascular Diseases, including heart disorders and heart-related mortality, are major health concerns, and the demand for diagnostic monitoring devices, such as Holter monitors, is on the rise. The market's growth is driven by the need for early detection and effective management of cardiovascular conditions, as well as advancements in technology, such as minimally invasive procedures and AI-based electrocardiogram technology. The Cardiovascular Devices Market is expected to continue growing, as healthcare systems in both developed and emerging nations seek to improve patient care and reduce the burden of cardiovascular diseases. With advancements in technology and a growing focus on preventative care, the market is poised for continued growth and innovation.

How is this Cardiovascular Medical Devices Industry segmented?

The cardiovascular medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Diagnostic systems
  Surgical devices


Disease Type

  Coronary artery disease
  Arrhythmia
  Heart failure
  Structural heart disease
  Others


End-user

  Hospitals
  ASCs
  Specialty clinics
  Home healthcare settings
  Rehabilitation centers


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Product Insights

The Diagnostic systems segment is estimated to witness significant growth during the forecast period. The market encompasses a vast array of technologies and devices designed to diagnose, monitor, and treat heart disorders and diseases. This market includes innovative solutions such as AI-based electrocardiogram (ECG) technology, implantable loop recorders, cardiac CT scans, and minimally invasive procedures for detecting clogged arteries and assessing heart function. Valves, pacemakers, stents, Holter monitors, and electrosurgical procedures are among the essential cardiovascular devices used for treating various heart conditions. The World Health Organization reports that cardiovascular diseases (CVDs) are the leading cause of heart-related mortality worldwide. Fatal conditions like atrial fibrillation, stroke, and heart attacks n

According to Cognitive Market Research, the global Cardiovascular Information System market size is USD 1.3 billion in 2024 and will expand at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031. Market Dynamics of Cardiovascular Information System Market

Key Drivers for Cardiovascular Information System Market

Rising Rate of Cardiovascular Illnesses- One of the main reasons the Cardiovascular Information System market is growing is the rising rate of cardiovascular illnesses. The rising frequency of cardiovascular disorders due to fast-paced lives and stress-related problems is predicted to drive up demand for cardiovascular information systems. Cardiovascular disorders account for the vast majority of deaths worldwide. According to a World Health Organization (WHO) estimate issued in 2019, 17.9 million deaths, or 32% of Cardiovascular diseases, were the leading cause of mortality worldwide. In 85% of these cases, a heart attack or stroke caused death. Heart attacks and strokes cause more than four out of every five CVD deaths, with one-third of fatalities occurring in persons under the age of 70. Cardiovascular disorders must be diagnosed as soon as possible so that therapy and medicine can begin, increasing the need for cardiovascular information systems. These technologies improve the productivity and efficiency of software and medical records. They are more efficient than previous ways of storing and analyzing cardiac data in patients; hence, their demand is higher.
The emergence of zero-footprint systems and data-driven technologies is anticipated to drive the Cardiovascular Information System market's expansion in the years ahead.

Key Restraints for Cardiovascular Information System Market

Risk of data breaches and stringent regulations for patient data protection
High initial expenses for product implementation and maintenance

Introduction of the Cardiovascular Information System Market

The Cardiovascular Information System (CIS) market is expanding rapidly, owing to the rising prevalence of cardiovascular diseases (CVDs), advances in healthcare information technology, and the growing demand for effective data administration in cardiology clinics. CIS are specialized electronic health record (EHR) systems that handle and streamline the massive amounts of data generated by cardiology departments. These solutions improve clinical decision-making, patient outcomes, and workflow efficiency. Additionally, Healthcare IT innovations such as cloud-based solutions, artificial intelligence (AI), and machine learning (ML) are revolutionizing CIS. These technologies improve data integration, predictive analytics, and individualized treatment regimens, resulting in increased market growth. Cardiac Information Systems help improve workflows in hospitals and cardiac departments. Improved data management, reporting, and communication among healthcare staff have a favorable impact on patient care and outcomes.

Retrieved from Mendeley Data on 16-Dec-2024: https://data.mendeley.com/datasets/x8ygrw87jw/1

This dataset comprises vital information on potential cerebral stroke patients, including personal data (e.g., age, gender, etc.), and disease history (e.g. hypertension, heart disease, etc.), which was collected from HealthData.gov by Liu, Fan & Wu (2019) during their study titled 'A hybrid machine learning approach to cerebral stroke prediction based on an imbalanced medical dataset'. The data collection prioritized physiological indicators over complex medical monitoring to minimize diagnosis expenses.

This cerebral stroke dataset records information from 43400 potential patients, comprising 12 attributes with various data types.

1. id - Unique identifier of each patient
2. gender - Gender of the patient: male, female, other
3. age - Age of the patient: ranged from 0.08 to 82
4. hypertension - If the patient has hypertension: 0, 1 (no, yes, respectively)
5. heart_disease - If the patient has heart disease: 0, 1 (no, yes, respectively)
6. ever_married - Marital status of patient: No, Yes
7. work_type - Occupation type of patient: children, private sector, self-employed, government sector, never worked
8. Residence_type - Residency type of patient: rural, urban
9. avg_glucose_level - Average glucose level in blood: ranged from 55 to 279.66
10. bmi - Body mass index: ranged from 10.1 to 97.6
11. smoking_status - Smoking status: formerly smoked, never smoked, smokes
12. stroke - If the patient has stroke: 0, 1 (no, yes, respectively)

The target variable, ‘stroke' is categorized into ‘0’ and ‘1’, representing ‘no stroke’ and ‘have stroke’ respectively. It is a categorical variable, making the problem a binary classification task. This dataset includes 783 occurrences of stroke, which account for 1.18% of the total, resulting in a highly imbalanced dataset. This imbalance reflects actual clinical practice, where most of the medical datasets suffer from class imbalance by nature.

Medical family illness assesses the presence and severity of medical problems of first degree family members, including pulmonary embolism, epilepsy, diabetes, hypertension, heart attack, stroke, migraine, cancer and miscarriage.

Snapshot img

Recording Chart Paper Market Size 2024-2028

The recording chart paper market size is forecast to increase by USD 753.71 million at a CAGR of 6.01% between 2023 and 2028.

The market is witnessing significant growth due to several key trends. The increasing adoption of automated systems across various industries is driving market growth. Automation in the healthcare, finance, and education sectors is leading to the replacement of traditional paper-based recording methods with digital alternatives. Another major trend is the increasing adoption of digital healthcare services, which is expected to boost the demand for electronic health records and digital chart papers. The internet has also facilitated remote patient monitoring and telemedicine, further expanding the market's scope. However, there are challenges that could hinder market growth. Resistance to change and reliance on traditional paper-based recording methods remain prevalent, particularly in certain industries and regions. Ensuring data security and privacy in digital recording systems is also a significant challenge that needs to be addressed to gain widespread acceptance.

What will be the Size of the Recording Chart Paper Market During the Forecast Period?

Request Free Sample

The market encompasses a range of products utilized in various healthcare facilities, including hospitals, diagnostic centers, clinics, labs, and diagnostic centres, for documenting and analyzing vital signs and physiological characteristics of patients. These charts are integral to cardiovascular disease management, with an estimated 17.9 million CVD deaths worldwide each year, necessitating constant monitoring for heart attacks and strokes. The market is driven by the growing geriatric population, who are more susceptible to cardiovascular conditions. Digital monitoring devices, such as ultrasound transducers and digital ECG sheets, are increasingly replacing traditional printed documents due to their convenience and accuracy.
Medical instruments and gadgets, including chart sheets for electrocardiography (ECG) and electroencephalography (EEG) papers, remain essential tools for healthcare professionals in managing and documenting patients' medical states.

How is this Recording Chart Paper Industry segmented and which is the largest segment?

The recording chart paper industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Hospitals
  Diagnostic centers
  Clinics


Type

  Cardiology monitoring recording
  Ambulatory and EMS recording
  Ultrasound and OB-GYN recording
  Fetal monitoring recording


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Application Insights

The hospitals segment is estimated to witness significant growth during the forecast period.

In the healthcare industry, chart paper plays a significant role in various medical departments and devices. In cardiology, it is used in electrocardiography (ECG) machines to document heart activity, contributing to the diagnosis and monitoring of cardiovascular diseases, including heart attacks and strokes. Neurology departments employ chart paper in electroencephalography (EEG) devices to measure brain electrical activity, essential for diagnosing conditions like epilepsy and other neurological disorders. Respiratory care units utilize chart paper in spirometry equipment for pulmonary function tests, aiding In the diagnosis of respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). Surgical suites incorporate chart paper in anesthesia monitors to record vital signs during procedures, ensuring patient safety.

Get a glance at the Recording Chart Paper Industry report of share of various segments Request Free Sample

The hospitals segment was valued at USD 798.07 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 42% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market holds a substantial share In the market due to advanced healthcare infrastructure, technological innovations, an aging population, and rising fertility rates. Cardiovascular diseases, including heart attacks and strokes, are major health concerns, driving the demand for recording chart papers in this region. Favorable government policies and research collaborations are expected to boost market growth, given the developed healthcare

China and India saw the largest number of air pollution-related deaths worldwide in 2021, with more than *********** recorded in each. Together, the world's two most populous countries accounted for approximately ** percent of global deaths from diseases linked to air pollution that year. Health effects of air pollution There are a number of health impacts linked to air pollution. These range from milder symptoms like sore throats and irritated eyes, to more serious effects that increase the risk of premature mortality, including strokes, heart disease, and lung cancer. Where is air pollution highest? In 2024, the world's most polluted countries based on PM2.5 concentrations were Chad, Bangladesh, and Pakistan, with average levels in each country more than ** times above World Health Organization (WHO) recommended guidelines. Although India ranked fifth that year, it was still home to ** of the ** most polluted cities in the world in 2024.

Between 1999 and 2024 (as of June 2024), around ** percent of clinical trials in China were for pharma products for non-communicable diseases. Around ** percent of clinical trials in India were for communicable, maternal, perinatal, and nutritional conditions. What are non-communicable diseases? Non-communicable diseases (NCDs), often referred to as chronic diseases, are noninfectious health conditions that are typically long-lasting and progress overtime. NCDs are often influenced by lifestyle, environmental factors, genetics, and aging. The main types of NCDs include cardiovascular diseases (such as heart attacks and stroke), cancers, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma) and diabetes. Among these NCDs, cancer is the leading focus area of pharmaceutical research and development worldwide. Scale of clinical trials in China China is a powerhouse in clinical research, conducting over ******* trials between 1999 and 2024, far surpassing other countries in the Asia-Pacific region. The majority of clinical trials in China are relatively small in scale, with nearly half of the trials involving fewer than 100 participants. Yet, around 76 clinical trials with more than ******* participants were conducted in China during this period, more than double the amount of clinical trials of this scale in Japan.